At its foundation, Continued Process Verification (CPV) is intended to inform manufacturers of process health as close to real-time as possible/practical through the use of statistical process control (SPC) and Process Capability analysis. It enables manufacturers to make changes to the process to keep them in the “sweet spot” and avoid off-spec production. Still in its formative stages, CPV stage 3 lacks the usual structured implementation blueprints that have accompanied most other FDA and EMA mandates. This whitepaper provides such a blueprint for success, leveraging a proven approach from a key supplier to pharmaceutical and life sciences industries, specialty chemicals manufacturers.

Download the complete whitepaper to:

• Learn about the regulatory and competitive imperatives driving CPV 
• Discover how Enterprise Manufacturing Intelligence requirements mirror those of CPV outlined by the FDA
• Key elements for delivering CPV